Please check your internet connection and try again.
# Sodium Phosphate Enema
## Overview
Sodium phosphate enema is a hypertonic saline solution that acts as a saline laxative by drawing water into the colon, which softens stool and stimulates bowel evacuation.
## Primary Indications
* Bowel preparation prior to colonoscopy or other colonic procedures.
* Relief of occasional constipation.
## Adult Dosing
* **Bowel Preparation:** Typically, one 4.5 fl oz (133 mL) bottle administered as a single dose. For optimal results, drink plenty of clear fluids before and after administration. Specific timing relative to the procedure will be dictated by local protocol and the procedure's time.
* **Constipation:** One 2.25 fl oz (67.5 mL) bottle administered as a single dose.
## Pediatric Dosing
* **Children 2 to under 12 years:** One 1.125 fl oz (33.75 mL) bottle.
* **Children under 2 years:** Safety and efficacy have not been established. Use is generally not recommended due to the risk of severe electrolyte imbalances and toxicity.
## Dose Adjustments
No specific dose adjustments are typically required for hepatic or renal impairment, but caution is advised in patients with pre-existing renal disease due to the potential for phosphate accumulation and hyperphosphatemia.
## Contraindications
* Congenital or acquired megacolon.
* Bowel obstruction.
* Congenital anomalies of the gastrointestinal tract.
* Heart failure.
* Severe renal impairment.
* Hypertension.
* Gastric retention.
* Children under 2 years of age.
* Patients on medications that may affect renal function or electrolyte balance (e.g., diuretics, ACE inhibitors).
* Patients with electrolyte disturbances, particularly hyperphosphatemia, hypocalcemia, or hypernatremia.
* Individuals on a sodium-restricted diet.
## Adverse Effects
* **Common:** Abdominal cramping, bloating, nausea, vomiting, diarrhea.
* **Serious:**
* **Electrolyte Imbalances:** Hyperphosphatemia, hypocalcemia, hypernatremia, hypokalemia. These can lead to cardiac arrhythmias, tetany, seizures, renal failure, and even death. Risk is increased in children, elderly patients, and those with impaired renal function or bowel obstruction.
* **Dehydration.**
* **Rectal irritation or bleeding.**
* **Rarely:** Allergic reactions.
## Key Drug Interactions
* **Diuretics (e.g., thiazides, loop diuretics):** Increased risk of electrolyte imbalances (hyperphosphatemia, hypocalcemia, hypernatremia).
* **ACE Inhibitors and Angiotensin Receptor Blockers (ARBs):** Increased risk of hyperkalemia and hyperphosphatemia.
* **NSAIDs:** May increase the risk of renal impairment and electrolyte disturbances.
* **Calcium supplements:** Can potentially worsen hyperphosphatemia.
## Monitoring
* Monitor for signs and symptoms of dehydration and electrolyte imbalances (e.g., confusion, lethargy, muscle cramps, cardiac palpitations, seizures).
* Electrolyte levels (phosphate, calcium, sodium, potassium) should be monitored, especially in at-risk populations or if adverse effects are suspected.
* Renal function (BUN, creatinine) should be assessed, particularly in patients with pre-existing renal disease.
## Clinical Pearls
* This product should be used with caution in all patients, especially children, the elderly, and those with renal insufficiency, heart failure, or bowel obstruction.
* Ensure adequate hydration with clear liquids before and after administration to minimize the risk of dehydration and electrolyte imbalances.
* Do not administer more frequently than recommended or for prolonged periods to avoid electrolyte disturbances.
* Proper administration technique is crucial to ensure efficacy and minimize adverse effects.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the official prescribing information and relevant clinical guidelines for the most up-to-date and complete drug information before making any treatment decisions.*
